REGENXBIO Inc. (RGNX) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $4.59M2017: $10.39M2018: $218.50M2019: $35.23M2020: $154.57M2021: $470.35M2022: $112.72M2023: $90.24M2024: $83.33M2025: $170.44M$170.44M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$170.44M+104.5%
2024$83.33M-7.7%
2023$90.24M-19.9%
2022$112.72M-76.0%
2021$470.35M+204.3%
2020$154.57M+338.7%
2019$35.23M-83.9%
2018$218.50M+2002.4%
2017$10.39M+126.5%
2016$4.59M